Jump to content
AMCP Learn
Search
Open menu
Cart
AMCP Learn login
Register
Bookmark/Search this post
Facebook
Twitter
LinkedIn
Forward
Home
Catalog
Help
Contact Us
FAQ
You are here
Home
Search
Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease
The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications
AMCP Talks: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions
Biosimilar Operational Readiness: Current and Future Market Landscape
Biosimilars in Vision: Addressing Drug Trends and Managed Care Strategies
Biosimilar Operational Readiness: Managed Care Stakeholder Preparation for Market Expansion
Evolving Strategies to Cover High Investment Medications
Innovations in Value-Based Partnerships for Patient Care Services
AMCP Partner Session: Managed Care Perspective on HIV Prevention - A Public Health Priority
Reducing Risk of Transplantation for People with IgA Nephropathy: What Managed Care Pharmacists Can Do to Help Optimize Treatment
Managing the Care of Ovarian Cancer With Poly(ADP-Ribose) Polymerase Inhibitors: A Managed Care Approach
Digital Therapeutics 101
Established Practices in Evaluating Data and Formulary Development for Digital Therapeutics
Operationalizing Prescription Digital Therapeutics: Challenges and Solutions to Adoption
Prescription Digital Therapeutics Data Exchange and Security
Medication Use Quality Continuing Education Program
Medication Use Quality Continuing Education Program
[DEMO] FMCP Module 1: Evolution and Principles of Managed Care
Shifting the Scales: Focus on Obesity and Managed Care Considerations
AMCP Market Insights Health Plan Best Practices: Implementing Continuous Glucose Monitoring Interventions to Improve Outcomes for Members with Diabetes
Navigating the Managed Care Residency Process: A Webinar for Student Pharmacists
AMCP Market Insights Health Plan Best Practices: Chronic Lymphocytic Leukemia (CLL)
[R2] Biosimilar Operational Readiness: Marketplace Trends and Regulatory Considerations
[K2] Understanding the 340B Program: Policy, Patients, and Practical Implications for Managed Care Professionals
[D4] Navigating NASH: A Discussion on Clinical Background, Patient Advocacy and Managed Care Considerations
Pages
1
2
3
4
5
6
7
next ›
last »
Search
Home
Catalog
Help
Contact Us
FAQ